June 17, 2026
Vedana Therapeutics
Vedana Therapeutics, a developer of migraine therapies, raised $46 million in Series A funding.
- Round
- Series A
- Amount raised
- $46M
- Lead investor
- Westlake BioPartners
- Industry
- —
- Headquarters
- Seattle, WA
- Employees
- —
- Website
- —
- —
Other investors
- Canaan Partners
- Dawn Biopharma
- Alexandria Venture Investments
Source: Axios Pro Rata